In the wake of the increase in Current Liabilities in the second quarter 2024, Quick Ratio fell to 0.02 a new company low.

Within Medical Equipment & Supplies industry 213 other companies have achieved higher Quick Ratio than Vapotherm Inc in second quarter 2024. While Quick Ratio total ranking in the second quarter 2024 has deteriorated compared to the prior quarter from 4025 to 4364.

Explain Quick Ratio?
How much Cash & cash equivalents VAPO�s has?
What are VAPO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VAPO Quick Ratio	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4	(Sep 30 2023) Q3	(Jun 30 2023) Q2
Y / Y Current Liabilities Change	954.19 %	823.31 %	-2.67 %	-17.94 %	-21.52 %
Y / Y Cash & cash equivalent Change	-83.87 %	-87.15 %	-38.21 %	-49.78 %	-63.91 %
Quick Ratio MRQ	0.02	0.02	0.54	0.96	1.3
VAPO's Total Ranking	# 4364	# 4025	# 2367	# 1979	# 1134
Seq. Current Liabilities Change	6.74 %	664.37 %	19.48 %	8.15 %	-6.51 %
Seq. Cash & cash equivalent Change	-12.11 %	-66.03 %	-32.55 %	-19.9 %	-30 %

Quick Ratio second quarter 2024 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 214
Healthcare Sector	# 965
Overall Market	# 4364

Quick Ratio Statistics
High	Average	Low
6.21	2.64	0.02
(Sep 30 2019)		(Jun 30 2024)

Financial Statements
Vapotherm Inc 's Current Liabilities	$ 146 Millions	Visit VAPO's Balance sheet
Vapotherm Inc 's Cash & cash equivalent	$ 3 Millions	Visit VAPO's Balance sheet
Source of VAPO's Sales		Visit VAPO's Sales by Geography

Cumulative Vapotherm Inc 's Quick Ratio

VAPO's Quick Ratio for the trailling 12 Months

VAPO Quick Ratio	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months
Y / Y Current Liabilities TTM Growth	383.38 %	165.57 %	-19.36 %	-12.41 %	-23.72 %
Y / Y Cash & cash equivalent TTM Growth	-65.57 %	-62.14 %	-59.43 %	-64.58 %	-64.76 %
Quick Ratio TTM	0.1	0.25	1.1	1.19	1.35
Total Ranking TTM	# 4139	# 3609	# 3539	# 1472	# 2505
Seq. Current Liabilities TTM Growth	72.01 %	198.21 %	-0.79 %	-5.01 %	-5.5 %
Seq. Cash & cash equivalent TTM Growth	-33.22 %	-33.02 %	-8.14 %	-16.21 %	-26.56 %

Quick ratio ranking by company, industry and sector >> Back to VAPO Financial Strength Comparisons >> Go to Compare VAPO Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2024 to $145.70 millions, cumulative Quick Ratio decreased to 0.1 below the Vapotherm Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 228 other companies have achieved higher Quick Ratio than Vapotherm Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 3609 to 4139.

Explain Quick Ratio?
How much Cash & cash equivalents VAPO�s has?
What are VAPO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 229
Healthcare Sector	# 1043
Within the Market	# 4139

trailing twelve months Quick Ratio Statistics
High	Average	Low
4.7	2.44	0.09
(Dec 31 2019)		(Jun 30 2024)

Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2024 MRQ Cash & cash equivalent	Jun 30 2024 MRQ Current Liabilities
Qhslab Inc	0.05	$ 0.104 Millions	$ 2.083 Millions
Vsee Health Inc	0.05	$ 1.106 Millions	$ 23.303 Millions
Global Innovative Platforms Inc.	0.05	$ 0.010 Millions	$ 0.217 Millions
Glucotrack Inc	0.04	$ 0.159 Millions	$ 3.660 Millions
Euda Health Holdings Limited	0.04	$ 0.376 Millions	$ 8.669 Millions
Sanuwave Health Inc	0.04	$ 2.460 Millions	$ 59.965 Millions
Ss Innovations International Inc	0.04	$ 0.608 Millions	$ 15.012 Millions
Petvivo Holdings Inc	0.04	$ 0.040 Millions	$ 1.091 Millions
The Pennant Group Inc	0.04	$ 3.043 Millions	$ 83.689 Millions
Bellevue Life Sciences Acquisition Corp	0.03	$ 0.119 Millions	$ 3.418 Millions
Premier Air Charter Holdings Inc	0.03	$ 0.007 Millions	$ 0.218 Millions
Biotricity Inc	0.03	$ 0.663 Millions	$ 21.552 Millions
Electromedical Technologies Inc	0.03	$ 0.117 Millions	$ 3.831 Millions
Yubo International Biotech Limited	0.03	$ 0.117 Millions	$ 3.953 Millions
Vycor Medical Inc	0.03	$ 0.125 Millions	$ 4.307 Millions
Interpace Biosciences Inc	0.03	$ 0.500 Millions	$ 19.030 Millions
Legacy Ventures International Inc	0.03	$ 0.001 Millions	$ 0.033 Millions
Vapotherm Inc	0.02	$ 2.904 Millions	$ 145.700 Millions
Cuprina Holdings cayman Limited	0.02	$ 0.086 Millions	$ 4.441 Millions
Mountain Crest Acquisition Corp V	0.02	$ 0.021 Millions	$ 1.098 Millions
Medicale Corp.	0.01	$ 0.000 Millions	$ 0.014 Millions
Sigyn Therapeutics Inc	0.01	$ 0.054 Millions	$ 3.900 Millions
Infusystem Holdings Inc	0.01	$ 0.146 Millions	$ 15.880 Millions
Catheter Precision Inc	0.00	$ 0.016 Millions	$ 3.318 Millions
Therapeutic Solutions International Inc	0.00	$ 0.008 Millions	$ 1.850 Millions

Date modified: 2026-09-26T07:36:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.